- Home
- Publications
- Publication Search
- Publication Details
Title
U0126: Not only a MAPK kinase inhibitor
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-25
DOI
10.3389/fphar.2022.927083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- U0126 pretreatment inhibits cisplatin-induced apoptosis and autophagy in HEI-OC1 cells and cochlear hair cells
- (2021) Dan Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- MEK1/2 inhibitor U0126, but not nimodipine, reduces upregulation of cerebrovascular contractile receptors after subarachnoid haemorrhage in rats
- (2019) Simon T. Christensen et al. PLoS One
- PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
- (2017) Xiaohui Zhang et al. International Journal of Clinical Oncology
- The restraining effect of baicalein and U0126 on human cervical cancer cell line HeLa
- (2017) Haiqiong Ye et al. Molecular Medicine Reports
- Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling
- (2017) Satoru Kake et al. ONCOLOGY REPORTS
- U0126 attenuates ischemia/reperfusion-induced apoptosis and autophagy in myocardium through MEK/ERK/EGR-1 pathway
- (2016) Anxing Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Regulatory Roles of MAPK Phosphatases in Cancer
- (2016) Heng Boon Low et al. Immune Network
- Crosstalk between JNK and NF-κB signaling pathways via HSP27 phosphorylation in HepG2 cells
- (2015) Jie Ruan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A systematic review of randomised controlled trials examining the effectiveness of breast and cervical cancer screening interventions for ethnic minority women
- (2015) Dorothy N.S. Chan et al. European Journal of Oncology Nursing
- U0126 inhibits pancreatic cancer progression via the KRAS signaling pathway in a zebrafish xenotransplantation model
- (2015) MENG GUO et al. ONCOLOGY REPORTS
- Hexachlorobenzene induces cell proliferation, and aryl hydrocarbon receptor expression (AhR) in rat liver preneoplastic foci, and in the human hepatoma cell line HepG2. AhR is a mediator of ERK1/2 signaling, and cell cycle regulation in HCB-treated HepG2 cells
- (2015) Ana Clara de Tomaso Portaz et al. TOXICOLOGY
- U0126 promotes osteogenesis of rat bone-marrow-derived mesenchymal stem cells by activating BMP/Smad signaling pathway
- (2014) Liangliang Xu et al. CELL AND TISSUE RESEARCH
- Inhibition of tumor growth by U0126 is associated with induction of interferon-γ production
- (2014) Xingzhe Ma et al. INTERNATIONAL JOURNAL OF CANCER
- TheERK1/2Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina
- (2013) Ghulam Mohammad et al. Journal of Diabetes Research
- Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
- (2012) Giacomo Cossa et al. CURRENT PHARMACEUTICAL DESIGN
- The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
- (2012) Antonella De Luca et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Pro-survival effects of JNK and p38 MAPK pathways in LPS-induced activation of BV-2 cells
- (2011) Christina Svensson et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Total ERK1/2 activity regulates cell proliferation
- (2011) Renaud Lefloch et al. CELL CYCLE
- The dual role of autophagy in cancer
- (2011) Eeva-Liisa Eskelinen CURRENT OPINION IN PHARMACOLOGY
- Emerging pathways and future targets for the molecular therapy of pancreatic cancer
- (2011) Vanja Vaccaro et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Requirement of c-Jun NH2-Terminal Kinase for Ras-Initiated Tumor Formation
- (2011) C. Cellurale et al. MOLECULAR AND CELLULAR BIOLOGY
- The novel dual PI3K/mTOR inhibitor GDC-0941 synergizes with the MEK inhibitor U0126 in non-small cell lung cancer cells
- (2011) Xiao-Hong Zhang Molecular Medicine Reports
- Photodynamic therapy (PDT) – Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines
- (2011) R.W.K. Wu et al. Photodiagnosis and Photodynamic Therapy
- Synergistic growth inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126
- (2010) M Ito et al. CANCER GENE THERAPY
- Autophagy: cellular and molecular mechanisms
- (2010) Danielle Glick et al. JOURNAL OF PATHOLOGY
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma
- (2009) F. Marampon et al. MOLECULAR CANCER THERAPEUTICS
- MEK inhibitor enhances the inhibitory effect of imatinib on pancreatic cancer cell growth
- (2008) Yuichi Takayama et al. CANCER LETTERS
- MEK-inhibitor U0126 in hyperglycaemic focal ischaemic brain injury in the rat
- (2008) N. Farrokhnia et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now